Table 5 Secondary outcomes regarding satisfaction level, length of PO hospital stays and adverse events
From: Duloxetine reduces pain after Total hip arthroplasty: a prospective, randomized controlled study
Duloxetine (n = 48) | Placebo (n = 48) | P value | |
|---|---|---|---|
Satisfaction level† (no.[%] of patients) | |||
Extremely satisfied | 19 (40%) | 11 (23%) | |
Very satisfied | 21 (44%) | 17 (35%) | |
Somewhat satisfied | 5 (10%) | 8 (17%) | |
Neither satisfied nor dissatisfied | 2 (4%) | 6 (13%) | |
Somewhat dissatisfied | 1 (2%) | 4 (8%) | |
Very dissatisfied | 0 | 2 (4%) | |
Extremely dissatisfied | 0 | 0 | |
length of PO hospital staysa (h) | 63.4 ± 17.6 | 70.7 ± 23.7 | 0.089 |
Adverse Events† (no.[%] of patients) | |||
Nausea and vomiting | 8 (17%) | 7 (15%) | 0.779 |
Dry mouth | 4 (8%) | 2 (4%) | 0.677 |
Insomnia | 5 (10%) | 6 (13%) | 0.749 |
Somnolence | 6 (13%) | 3 (6%) | 0.486 |
Constipation | 7 (15%) | 9 (19%) | 0.584 |
Dizziness | 3 (6%) | 4 (8%) | 1.000 |
Fatigue | 5 (10%) | 7 (15%) | 0.537 |